Chemotherapy for leukemia: types, protocols, and timelines. Administration routes, side effects, outcomes, and supportive care in our web story.
PROCESS, DRUGS, TIPS
Leukemia is uncontrolled growth of abnormal blood cells in marrow, impairing normal cell production. Fatigue, infections, and easy bruising are common.
Acute (ALL, AML) progresses fast and needs prompt therapy. Chronic (CLL, CML) is slower with varied options. The leukemia type guides the plan.
Chemotherapy targets fast growing leukemia cells, slows spread, and aims for remission. It is the primary therapy for many leukemia types.
Drugs are given IV, orally, or intrathecally; they circulate systemically and target marrow. Route depends on leukemia type and patient factors.
ALL: induction consolidation maintenance. AML: “7+3” then consolidation. CLL: chemo targeted therapy. CML: TKIs central; chemo limited.
Induction achieves rapid response; consolidation lowers relapse; maintenance sustains remission. ALL often 2 - 3 years; AML about 6 - 12 months.
Fatigue, nausea, hair loss, and infection risk are common. Nutrition support, prophylaxis, medications, and rest help preserve quality of life.
Remission rates vary by type and genetics. Stem cell transplant, targeted therapies, and immunotherapy are options for selected patients.
Balanced nutrition, hygiene, and prophylaxis reduce infection risk. Counseling, support groups, and rest improve adherence and quality of life.